Transmission dynamics and mutational prevalence of the novel Severe acute respiratory syndrome coronavirus‐2 Omicron Variant of Concern
Open Access
- 4 February 2022
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (5) , 2160-2166
Abstract
The novel Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) variant, Omicron (PANGO lineage B.1.1.529) is being reported from all around the world. The WHO has categorized Omicron as a Variant of Concern (VOC) considering its higher transmissibility and infectivity, vaccine breakthrough cases. As of January 6, 2022, Omicron has been reported in at least 149 countries. Therefore, this study was planned to investigate the transmission dynamics and mutational prevalence of the novel SARS‐CoV‐2 Omicron variant. The transmission dynamics and Omicron SARS‐CoV‐2 divergence was studied using GISAID and Nextstrain which provides information about the genetic sequences, epidemiological, geographical, and species‐specific data of human, avian, and animal viruses. Further, the mutation prevalence in spike glycoprotein of Omicron was studied, and the frequency of the crucial mutations was compared with the other prevalent VOCs. The transmission dynamics suggest that the Omicron was first identified in South Africa and then it was reported in the United Kingdom followed by the United States and Australia. Further, our phylogenetic analysis suggests that Omicron (BA.1) was clustered distinctly from the other VOCs. In the Spike glycoprotein, the Omicron (B.1.1.529) demonstrates critical 32 amino acid changes. This study may help us to understand mutational hotspots, transmission dynamics, phylogenetic divergence, effect on testing and immunity, which shall promote the progress of the clinical application and basic research.Keywords
This publication has 25 references indexed in Scilit:
- Therapeutic approaches for SARS-CoV-2 infectionMethods, 2021
- Structural and molecular perspectives of SARS-CoV-2Methods, 2021
- SARS-CoV-2 variants, spike mutations and immune escapeNature Reviews Microbiology, 2021
- The new SARS-CoV-2 strain shows a stronger binding affinity to ACE2 due to N501Y mutantMedicine in Drug Discovery, 2021
- Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2Wellcome Open Research, 2021
- Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodiesNature Medicine, 2021
- Understanding the possible origin and genotyping of the first Bangladeshi SARS‐CoV‐2 strainJournal of Medical Virology, 2020
- Structural, glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and SARS coronavirus (SARS-CoV)VirusDisease, 2020
- GISAID: Global initiative on sharing all influenza data – from vision to realityEurosurveillance, 2017
- Data, disease and diplomacy: GISAID's innovative contribution to global healthGlobal Challenges, 2017